GLP‑1 Agonists Linked to Lower Clot Risk and Mortality in People With Obesity and Autoimmune Disease
A large electronic health record target‑trial emulation found lower rates of stroke, pulmonary embolism, ED visits, and death but authors say randomized trials are needed to test causality.
